Novo CEO pressed by Senate to chop costs of obesity, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the corporate would contemplate new talks with insurers concerning the list selling prices of Wegovy and copyright whenever they pledge to keep the medicines on their formularies. Sanders swiftly condemned https://label-the-figure-with-the19741.kylieblog.com/31143875/indicators-on-healthcare-news-you-should-know